CYP1B1 and intervertebral disk degenerative disorder: Two of these targets, cytochrome P450 family 1 subfamily B member 1 (CYP1B1) and tumour necrosis factor alpha-induced protein 6 (TNFAIP6), were chosen as key targets because they demonstrated a significant difference in expression in IDD.